Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Elisei

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Journal of Endocrinological Investigation|December 21, 2023
IgG4 serum levels in Graves' orbitopathyS Comi, G Lanzolla, G Cosentino, et al.
The Journal of Endocrinology|September 8, 2004
Thyroid papillary carcinoma: preliminary evidence for a germ-line single nucleotide polymorphism in the Fas geneF Basolo, R Giannini, P Faviana, et al.
Heliyon|May 30, 2024
Current landscape and support for practical initiation of oncological prehabilitation translatable to thyroid cancer: A position paperS Jack, E Andritsch, A Joaquim, et al.
Journal of Endocrinological Investigation|February 1, 1988
Thyroid carcinoma in thyrotoxic patients treated by surgeryF Pacini, R Elisei, G C Di Coscio, et al.
Journal of Endocrinological Investigation|July 27, 2013
Follicular-derived neoplasms: morphometric and genetic differencesA Proietti, C Sartori, N Borrelli, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptorP Vitti, R Elisei, M Tonacchera, et al.
Thyroid : Official Journal of the American Thyroid Association|September 29, 2001
Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patientsF Pacini, R Elisei, M Capezzone, et al.
Surgery|December 1, 1995
Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutationsF Pacini, C Romei, P Miccoli, et al.
Oncogene|August 22, 2000
The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathwayH I Saavedra, J A Knauf, J M Shirokawa, et al.
The Journal of Clinical Endocrinology and Metabolism|December 12, 2001
Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinomaF Pacini, E Molinaro, F Lippi, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Journal of Endocrinological Investigation|December 21, 2023
IgG4 serum levels in Graves' orbitopathyS Comi, G Lanzolla, G Cosentino, et al.
The Journal of Endocrinology|September 8, 2004
Thyroid papillary carcinoma: preliminary evidence for a germ-line single nucleotide polymorphism in the Fas geneF Basolo, R Giannini, P Faviana, et al.
Heliyon|May 30, 2024
Current landscape and support for practical initiation of oncological prehabilitation translatable to thyroid cancer: A position paperS Jack, E Andritsch, A Joaquim, et al.
Journal of Endocrinological Investigation|February 1, 1988
Thyroid carcinoma in thyrotoxic patients treated by surgeryF Pacini, R Elisei, G C Di Coscio, et al.
Journal of Endocrinological Investigation|July 27, 2013
Follicular-derived neoplasms: morphometric and genetic differencesA Proietti, C Sartori, N Borrelli, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptorP Vitti, R Elisei, M Tonacchera, et al.
Thyroid : Official Journal of the American Thyroid Association|September 29, 2001
Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patientsF Pacini, R Elisei, M Capezzone, et al.
Surgery|December 1, 1995
Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutationsF Pacini, C Romei, P Miccoli, et al.
Oncogene|August 22, 2000
The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathwayH I Saavedra, J A Knauf, J M Shirokawa, et al.
The Journal of Clinical Endocrinology and Metabolism|December 12, 2001
Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinomaF Pacini, E Molinaro, F Lippi, et al.
Pageof 11